Financhill
Back

Blueprint Medicines 10K Form

Sell
24

BPMC
Blueprint Medicines

Last Price:
$92.48
Seasonality Move:
5.74%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive BPMC News And Ratings

See the #1 stock for the next 7 days that we like better than BPMC

BPMC Financial Statistics

Sales & Book Value

Annual Sales: $508.8M
Cash Flow: $-30.3M
Price / Cash Flow: 0
Annual Sales: $4.69
Price / Book: 20.1

Profitability

EPS (TTM): -1.08000
Net Income (TTM): $-67.1M
Gross Margin: $488.7M
Return on Equity: -24.43%
Return on Assets: -5.92%

Blueprint Medicines Earnings Forecast

Key Blueprint Medicines Financial Ratios

  • The Gross Profit Margin over the past 10 years for BPMC is 96.04%.
  • The Selling, General & Administrative Expenses for BPMC have been equal to 70.61% of Gross Profit Margin.
  • The Research & Development expenses have been 67.10% of Revenue.
  • The Net Earning history of BPMC is -13.19% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 6 years.

Blueprint Medicines Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BPMC
CUSIP: 09627Y
Website: blueprintmedicines.com

Debt

Debt-to-Equity Ratio: 1.3
Current Ratio: 2.85
Quick Ratio: 2.66

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 66.54

BPMC Technical Analysis vs Fundamental Analysis

Sell
24
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy or a Sell?